Holger Gellermann

445 total citations
7 papers, 335 citations indexed

About

Holger Gellermann is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Holger Gellermann has authored 7 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Holger Gellermann's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Holger Gellermann is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Holger Gellermann collaborates with scholars based in Germany, Spain and United States. Holger Gellermann's co-authors include Henry F. Chambers, Mark Z. Jacobson, Heiko Jessen, Christoph Boesecke, Stefan Fenske, Bernhard Zöllner, Karin J. Metzner, Vincent Soriano, Hans‐Jürgen Stellbrink and Knud Schewe and has published in prestigious journals such as The American Journal of Medicine, The Journal of Infectious Diseases and European Journal of Cancer.

In The Last Decade

Holger Gellermann

7 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holger Gellermann Germany	6	253	165	110	35	31	7	335
Paola Tatarelli Italy	11	145 0.6×	60 0.4×	119 1.1×	26 0.7×	50 1.6×	23	303
C.-A. Siegrist Switzerland	5	204 0.8×	97 0.6×	109 1.0×	23 0.7×	59 1.9×	10	327
Ruxandra Câlin France	14	253 1.0×	211 1.3×	130 1.2×	52 1.5×	46 1.5×	35	433
Chun-Yuan Lee Taiwan	10	140 0.6×	59 0.4×	103 0.9×	11 0.3×	24 0.8×	31	314
Stella Pendle South Africa	11	215 0.8×	68 0.4×	198 1.8×	22 0.6×	12 0.4×	19	361
Roberta Prinapori Italy	11	215 0.8×	68 0.4×	146 1.3×	11 0.3×	24 0.8×	24	311
Sung‐Hsi Huang Taiwan	11	201 0.8×	81 0.5×	138 1.3×	16 0.5×	27 0.9×	34	301
Cathy Wilfert United States	5	175 0.7×	62 0.4×	123 1.1×	18 0.5×	14 0.5×	6	266
H.R. Brodt Germany	10	100 0.4×	28 0.2×	111 1.0×	45 1.3×	33 1.1×	14	259
Gabriel Mestre Spain	8	223 0.9×	188 1.1×	65 0.6×	32 0.9×	49 1.6×	11	352

Countries citing papers authored by Holger Gellermann

Since Specialization

Citations

This map shows the geographic impact of Holger Gellermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Gellermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Gellermann more than expected).

Fields of papers citing papers by Holger Gellermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Gellermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Gellermann. The network helps show where Holger Gellermann may publish in the future.

Co-authorship network of co-authors of Holger Gellermann

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Gellermann. A scholar is included among the top collaborators of Holger Gellermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Gellermann. Holger Gellermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Seclén, Eduardo, Vincent Soriano, Luz Martı́n-Carbonero, et al.. (2011). Impact of Baseline HIV-1 Tropism on Viral Response and CD4 Cell Count Gains in HIV-Infected Patients Receiving First-line Antiretroviral Therapy. The Journal of Infectious Diseases. 204(1). 139–144. 26 indexed citations

Soriano, Vincent, Keikawus Arastéh, Thomas A. Lutz, et al.. (2010). Nevirapine versus Atazanavir/Ritonavir, Each Combined with Tenofovir Disoproxil Fumarate/Emtricitabine, in Antiretroviral-Naive HIV-1 Patients: The Arten Trial. Antiviral Therapy. 16(3). 339–348. 69 indexed citations

Seclén, Eduardo, María del Mar González, Luz Martı́n-Carbonero, et al.. (2010). Impact of baseline HIV‐1 tropism on viral response and CD4 gains in antiretroviral‐naïve patients. Journal of the International AIDS Society. 13(S4). 5 indexed citations

Metzner, Karin J., Pia Rauch, Hauke Walter, et al.. (2005). Detection of minor populations of drug-resistant HIV-1 in acute seroconverters. AIDS. 19(16). 1819–1825. 86 indexed citations

Weh, H.J., M. Hoffknecht, Peter Holzer, et al.. (1995). 754 5-FU/FA IV bolus therapy vs weekly high-dose 5-FU/FA 24-hour infusion in metastatic colorectal carcinoma: Preliminary results of an ongoing randomized phase III study. European Journal of Cancer. 31. S158–S158. 2 indexed citations

Jacobson, Mark Z., Holger Gellermann, & Henry F. Chambers. (1988). Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and aids-related complex. The American Journal of Medicine. 85(2). 172–176. 140 indexed citations

Gellermann, Holger, et al.. (1988). Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex1. The American Journal of Medicine. 85. 172–176. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact